VCANBIO CELL & GENE ENGINEERING CORP., LTD

Income Statement Vcanbio Cell & Gene Engineering Corp., Ltd

Equities

600645

CNE000000545

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 08/05/2026			5-day change	1st Jan Change
24.85 ^CNY	-0.52%		-3.94%	-1.39%

04-24	Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
29/10/25	Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2025	CI

a5c27125.ZwFuo-39MHFUl3aRr-HR48qnVBf6W8CNlXUAsn48B0c.X2sl-9-2Xzo33wzYnbW5qY_lHXivDbrAw0JI4TtwKjRSMir3q5tHJh_TRg

Published financial data: VCANBIO CELL & GENE ENGINEERING CORP., LTD

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.5B	1.51B	1.54B	1.55B	1.45B
Other Revenues, Total	37.94M	47.8M	52.07M	35.81M	-
Total Revenues	1.54B	1.55B	1.59B	1.59B	1.45B
Cost of Goods Sold, Total	474M	511M	505M	498M	439M
Gross Profit	1.06B	1.04B	1.08B	1.09B	1.02B
Selling General & Admin Expenses, Total	750M	723M	721M	695M	655M
Provision for Bad Debts	36.89M	14.56M	23.12M	27.65M	-
R&D Expenses	134M	146M	183M	182M	149M
Other Operating Expenses	16.54M	17.59M	19.19M	19.39M	15.72M
Other Operating Expenses, Total	937M	901M	947M	924M	820M
Operating Income	124M	143M	138M	163M	197M
Interest Expense, Total	-3.14M	-4.02M	-5.02M	-5.03M	-
Interest And Investment Income	16.21M	18.23M	29.59M	24.4M	-
Net Interest Expenses	13.07M	14.22M	24.57M	19.36M	-
Income (Loss) On Equity Invest.	-	-	-11.85M	-14.3M	-
Currency Exchange Gains (Loss)	105K	-2.37M	1.51M	-3.2M	-
Other Non Operating Income (Expenses)	-1.49M	-2M	1.03M	-3.22M	-5.49M
EBT, Excl. Unusual Items	136M	153M	153M	162M	191M
Impairment of Goodwill	-19.72M	-	-	-	-
Gain (Loss) On Sale Of Investments	79.09M	-8.71M	-36.09M	-30.03M	-7.92M
Gain (Loss) On Sale Of Assets	514K	1.24M	3.67M	1.3M	6.41M
Asset Writedown	-6.26M	-	-313K	-4.68M	-15.11M
Other Unusual Items	33.2M	9.9M	11.92M	7.52M	-
EBT, Incl. Unusual Items	223M	155M	133M	136M	174M
Income Tax Expense	71.75M	48.53M	34.03M	46.59M	70.92M
Earnings From Continuing Operations	151M	107M	98.55M	89.35M	104M
Net Income to Company	151M	107M	98.55M	89.35M	104M
Minority Interest	4.11M	6.3M	7.9M	11M	10.3M
Net Income - (IS)	155M	113M	106M	100M	114M
Net Income to Common Incl Extra Items	155M	113M	106M	100M	114M
Net Income to Common Excl. Extra Items	155M	113M	106M	100M	114M
Per Share Items
Net EPS - Basic	0.33	0.24	0.23	0.22	0.25
Basic EPS - Continuing Operations	0.33	0.24	0.23	0.22	0.25
Basic Weighted Average Shares Outstanding	471M	471M	463M	456M	455M
Net EPS - Diluted	0.33	0.24	0.23	0.22	0.25
Diluted EPS - Continuing Operations	0.33	0.24	0.23	0.22	0.25
Diluted Weighted Average Shares Outstanding	471M	471M	463M	456M	455M
Normalized Basic EPS	0.19	0.22	0.22	0.25	0.28
Normalized Diluted EPS	0.19	0.22	0.22	0.25	0.28
Payout Ratio	1.03	-	-	-	-
Supplemental Items
EBITDA	220M	247M	244M	266M	336M
EBITA	138M	155M	151M	175M	216M
EBIT	124M	143M	138M	163M	197M
EBITDAR	222M	249M	246M	266M	-
Total Revenues (As Reported)	1.54B	1.55B	1.59B	1.59B	-
Effective Tax Rate - (Ratio)	32.18	31.26	25.67	34.27	40.65
Total Current Taxes	50.39M	55.82M	71.32M	67.27M	-
Total Deferred Taxes	21.36M	-7.29M	-37.28M	-20.67M	-
Normalized Net Income	89.19M	102M	104M	112M	130M
Interest on Long-Term Debt	1.64M	4.02M	4.1M	5.03M	-
Non-Cash Pension Expense	3.41M	2.57M	2.11M	5.78M	-
Supplemental Operating Expense Items
Advertising Expense	32.43M	29.02M	32.98M	30.86M	-
Marketing Expenses	129M	134M	106M	75.42M	-
Selling and Marketing Expenses	408M	393M	374M	350M	305M
General and Administrative Expenses	341M	330M	346M	345M	350M
Research And Development Expense From Footnotes	135M	147M	184M	182M	149M
Net Rental Expense, Total	2.63M	2.68M	2.24M	678K	-
Imputed Operating Lease Interest Expense	941K	770K	668K	217K	-
Imputed Operating Lease Depreciation	1.69M	1.91M	1.57M	461K	-
Maintenance & Repair Expenses, Total	6.12M	5.14M	5.05M	4.05M	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.2B	1.39B	1.58B	1.52B	1.01B
Trading Asset Securities, Total	-	-	-	-	712M
Total Cash And Short Term Investments	1.2B	1.39B	1.58B	1.52B	1.72B
Accounts Receivable, Total	511M	576M	611M	645M	608M
Other Receivables	16.58M	28.41M	18.09M	11.6M	13.84M
Total Receivables	528M	604M	629M	657M	621M
Inventory	227M	248M	248M	232M	230M
Prepaid Expenses	2.98M	2.29M	3.37M	508K	-
Other Current Assets, Total	77.08M	61.82M	47.36M	42.08M	85.78M
Total Current Assets	2.03B	2.31B	2.51B	2.46B	2.66B
Gross Property Plant And Equipment	1.27B	1.32B	1.35B	1.44B	-
Accumulated Depreciation	-505M	-554M	-641M	-747M	-
Net Property Plant And Equipment	766M	766M	705M	689M	614M
Long-term Investments	887M	804M	780M	737M	733M
Goodwill	703M	703M	703M	703M	703M
Other Intangibles, Total	134M	112M	101M	100M	84.7M
Accounts Receivable Long-Term	65.9M	52M	37.45M	28.47M	-
Deferred Tax Assets Long-Term	46.94M	56.02M	81.8M	92.95M	50.46M
Deferred Charges Long-Term	141M	149M	160M	165M	167M
Other Long-Term Assets, Total	260M	333M	334M	277M	284M
Total Assets	5.03B	5.28B	5.41B	5.25B	5.29B
Liabilities
Accounts Payable, Total	31.76M	56.85M	68.76M	47.32M	97.45M
Accrued Expenses, Total	133M	135M	147M	170M	84.27M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	6.31M	6.31M	6.31M	-	21.39M
Current Portion of Leases	16.69M	21.19M	23.34M	43.75M	-
Current Income Taxes Payable	24.97M	30.38M	17.93M	6.71M	33.79M
Unearned Revenue Current, Total	1.08B	1.11B	1.14B	1.13B	1.13B
Other Current Liabilities	106M	110M	81.29M	85.4M	89.21M
Total Current Liabilities	1.4B	1.47B	1.48B	1.49B	1.46B
Long-Term Debt	22.08M	15.77M	9.46M	-	-
Long-Term Leases	37.11M	97.9M	88.37M	80M	47.28M
Unearned Revenue Non Current	11.08M	10.92M	10.02M	9.56M	10.08M
Deferred Tax Liability Non Current	34.7M	34.87M	23.15M	12.95M	10.55M
Other Non Current Liabilities	-	-	-	-	11.6M
Total Liabilities	1.5B	1.63B	1.61B	1.59B	1.54B
Common Stock, Total	468M	468M	468M	468M	468M
Additional Paid In Capital	3.38B	3.38B	3.38B	3.37B	3.39B
Retained Earnings	-514M	-401M	-294M	-194M	-80.09M
Treasury Stock	-	-	-	-200M	-200M
Comprehensive Income and Other	126M	105M	133M	148M	130M
Total Common Equity	3.46B	3.56B	3.68B	3.6B	3.71B
Minority Interest	69.31M	97.85M	115M	63.98M	48.24M
Total Equity	3.53B	3.65B	3.8B	3.66B	3.75B
Total Liabilities And Equity	5.03B	5.28B	5.41B	5.25B	5.29B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	468M	468M	468M	456M	472M
ECS Total Common Shares Outstanding	468M	468M	468M	456M	472M
Book Value / Share	7.4	7.6	7.87	7.89	7.85
Tangible Book Value	2.63B	2.74B	2.88B	2.79B	2.92B
Tangible Book Value Per Share	5.61	5.86	6.15	6.12	6.18
Total Debt	82.2M	141M	127M	124M	68.67M
Net Debt	-1.11B	-1.25B	-1.45B	-1.4B	-1.65B
Debt Equivalent Oper. Leases	21.08M	21.41M	17.88M	5.42M	-
Minority Interest, Total (Incl. Fin. Div)	69.31M	97.85M	115M	63.98M	48.24M
Equity Method Investments, Total	248M	223M	217M	199M	-
Account Code - Inventory Valuation	6	6	6	6	-
Inventories - Raw Materials, Total	53.39M	65.13M	61.51M	59.29M	-
Inventories - Work In Process, Total	10.83M	15.05M	18.51M	19.47M	-
Inventories - Finished Goods, Total	212M	223M	233M	54.69M	-
Inventories - Others	1.07M	1.39M	1.15M	166M	-
Land - (BS)	3.14M	3.43M	3.49M	3.54M	-
Buildings, Total	558M	498M	483M	547M	-
Machinery, Total	624M	653M	691M	701M	-
Full Time Employees	2.23K	2.33K	2.21K	2.01K	-
Accumulated Allowance for Doubtful Accounts (Supple)	123M	137M	161M	187M	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	155M	113M	106M	100M	104M
Depreciation & Amortization - CF	104M	119M	123M	122M	120M
Amortization of Goodwill and Intangible Assets - (CF)	13.09M	12.43M	12.84M	11.85M	19.57M
Depreciation & Amortization, Total	117M	131M	136M	133M	139M
Amortization of Deferred Charges, Total - (CF)	30.82M	33.29M	36.92M	36.67M	25.64M
(Gain) Loss From Sale Of Asset	-1.49M	-2.03M	-3.67M	-1.3M	-6.41M
(Gain) Loss on Sale of Investments - (CF)	-85.87M	8.71M	47.94M	44.33M	13.67M
Asset Writedown & Restructuring Costs	26.96M	607K	313K	4.68M	10.69M
Provision and Write-off of Bad Debts	38.88M	17.82M	20.9M	27.68M	-
Other Operating Activities, Total	-5.18M	-2.04M	2.09M	3.12M	18.02M
Change In Accounts Receivable	30.73M	-31.93M	-12.23M	-31.23M	-20.2M
Change In Inventories	-4.56M	-27.64M	-9.25M	-633K	-7.36M
Change In Accounts Payable	19.42M	35.06M	-1.07M	-11.18M	-3.37M
Change In Deferred Taxes	18.49M	-7.29M	-37.28M	-20.67M	40.1M
Change in Other Net Operating Assets	-19.46M	-6.68M	12.21M	-25.15K	-
Cash from Operations	321M	262M	299M	285M	314M
Capital Expenditure	-128M	-99.19M	-88.61M	-67.32M	-49.56M
Sale of Property, Plant, and Equipment	12.63M	1.42M	187K	780K	307K
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-18.95M	-572K	-2.06M	1.95M	-710M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	-	-	-	724K	11.74M
Cash from Investing	-134M	-98.34M	-90.49M	-63.86M	-748M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-29.13M	-41.33M	-35.76M	-41.19M	-
Total Debt Repaid	-29.13M	-41.33M	-35.76M	-41.19M	-
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-	-	-	-200M	-
Common Dividends Paid	-1.61M	-	-	-	-
Common & Preferred Stock Dividends Paid	-1.61M	-	-	-	-
Other Financing Activities, Total	-18.97M	33.58M	17.03M	-43.69M	-74.1M
Cash from Financing	-49.71M	-7.75M	-18.73M	-285M	-74.1M
Foreign Exchange Rate Adjustments	-7.44M	35.3M	10.22M	7.3M	-9.25M
Net Change in Cash	130M	191M	200M	-56.28M	-518M
Supplemental Items
Cash Interest Paid	-	1.27M	917K	591K	-
Cash Income Tax Paid (Refund)	117M	111M	171M	162M	159M
Levered Free Cash Flow	198M	141M	165M	189M	225M
Unlevered Free Cash Flow	200M	144M	168M	192M	225M
Change In Net Working Capital	-102M	10.69M	2.56M	12.53M	13.21M
Net Debt Issued / Repaid	-29.13M	-41.33M	-35.76M	-41.19M	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	1.57	1.73	1.61	1.91	2.33
Return on Total Capital	2.17	2.41	2.24	2.65	3.23
Return On Equity %	4.3	2.97	2.64	2.4	2.79
Return on Common Equity	4.53	3.22	2.94	2.76	3.12
Margin Analysis
Gross Profit Margin %	69.14	67.16	68.23	68.6	69.84
SG&A Margin	48.84	46.52	45.37	43.86	45.01
EBITDA Margin %	14.3	15.86	15.35	16.75	23.08
EBITA Margin %	8.96	9.99	9.5	11.04	14.85
EBIT Margin %	8.11	9.19	8.69	10.29	13.51
Income From Continuing Operations Margin %	9.85	6.86	6.2	5.64	7.12
Net Income Margin %	10.12	7.27	6.7	6.33	7.82
Net Avail. For Common Margin %	10.12	7.27	6.7	6.33	7.82
Normalized Net Income Margin	5.81	6.55	6.53	7.07	8.92
Levered Free Cash Flow Margin	12.9	9.09	10.36	11.93	15.47
Unlevered Free Cash Flow Margin	13.02	9.25	10.55	12.12	15.47
Asset Turnover
Asset Turnover	0.31	0.3	0.3	0.3	0.28
Fixed Assets Turnover	2.05	2.03	2.16	2.27	2.23
Receivables Turnover (Average Receivables)	2.93	2.77	2.59	2.47	2.32
Inventory Turnover (Average Inventory)	2.11	2.15	2.04	2.07	1.9
Short Term Liquidity
Current Ratio	1.45	1.57	1.69	1.65	1.82
Quick Ratio	1.23	1.36	1.49	1.47	1.61
Operating Cash Flow to Current Liabilities	0.23	0.18	0.2	0.19	0.22
Days Sales Outstanding (Average Receivables)	124.75	131.62	140.82	148.26	157.11
Days Outstanding Inventory (Average Inventory)	173.07	169.79	179.24	176.51	192.33
Average Days Payable Outstanding	28.6	30.54	45.41	44.07	60.48
Cash Conversion Cycle (Average Days)	269.23	270.87	274.65	280.7	288.96
Long Term Solvency
Total Debt/Equity	2.33	3.86	3.36	3.38	1.83
Total Debt / Total Capital	2.27	3.72	3.25	3.27	1.8
LT Debt/Equity	1.68	3.11	2.58	2.19	1.26
Long-Term Debt / Total Capital	1.64	3	2.49	2.11	1.24
Total Liabilities / Total Assets	29.81	30.86	29.8	30.29	29.05
EBIT / Interest Expense	39.64	35.59	27.53	32.42	-
EBITDA / Interest Expense	76.87	68.23	54.57	58.91	-
(EBITDA - Capex) / Interest Expense	36.18	43.52	36.91	45.54	-
Total Debt / EBITDA	0.34	0.52	0.47	0.42	0.2
Net Debt / EBITDA	-4.61	-4.57	-5.31	-4.72	-4.91
Total Debt / (EBITDA - Capex)	0.72	0.81	0.69	0.54	0.24
Net Debt / (EBITDA - Capex)	-9.8	-7.16	-7.85	-6.11	-5.75
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	16.41	1.27	2.24	-0.27	-8.23
Gross Profit, 1 Yr. Growth %	22.32	-1.62	3.84	0.27	-6.58
EBITDA, 1 Yr. Growth %	11.58	8.46	-3.82	-5.76	26.49
EBITA, 1 Yr. Growth %	22.67	6.95	-7.03	10.99	23.46
EBIT, 1 Yr. Growth %	33.08	14.86	-3.35	18.14	20.43
Earnings From Cont. Operations, 1 Yr. Growth %	-219.14	-29.45	-7.62	-9.33	15.86
Net Income, 1 Yr. Growth %	-222.43	-27.26	-5.78	-5.73	13.43
Normalized Net Income, 1 Yr. Growth %	5.18	14.12	7.19	8.07	15.66
Diluted EPS Before Extra, 1 Yr. Growth %	-222.22	-27.27	-4.17	-4.35	13.64
Accounts Receivable, 1 Yr. Growth %	-0.33	12.73	6	5.64	-5.79
Inventory, 1 Yr. Growth %	2.05	9.31	-0.08	-6.33	-0.85
Net Property, Plant and Equip., 1 Yr. Growth %	4.45	-0.07	-7.86	-2.36	-10.85
Total Assets, 1 Yr. Growth %	3.15	4.99	2.4	-3	0.82
Tangible Book Value, 1 Yr. Growth %	3.99	4.36	5.06	-3.06	4.56
Common Equity, 1 Yr. Growth %	1.98	2.67	3.61	-2.42	3.1
Cash From Operations, 1 Yr. Growth %	31.35	-18.4	14.18	-4.62	9.97
Capital Expenditures, 1 Yr. Growth %	39.27	-22.35	-10.66	-24.03	-26.38
Levered Free Cash Flow, 1 Yr. Growth %	41.81	-28.65	16.55	14.84	19.02
Unlevered Free Cash Flow, 1 Yr. Growth %	40.84	-28.09	16.7	14.57	17.07
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.22	8.58	1.76	0.98	-4.33
Gross Profit, 2 Yr. CAGR %	6.52	9.7	1.09	2.04	-3.21
EBITDA, 2 Yr. CAGR %	-10.57	11.93	3.61	2.3	9.18
EBITA, 2 Yr. CAGR %	-16.32	17.72	1.95	3.82	17.06
EBIT, 2 Yr. CAGR %	-16.47	23.63	5.36	6.86	19.28
Earnings From Cont. Operations, 2 Yr. CAGR %	67.41	-8.32	-19.27	-8.48	2.49
Net Income, 2 Yr. CAGR %	76.79	-5.63	-17.21	-5.76	3.41
Normalized Net Income, 2 Yr. CAGR %	-7.44	9.56	7.86	7.63	11.8
Diluted EPS Before Extra, 2 Yr. CAGR %	73.21	-5.72	-16.52	-4.26	4.26
Accounts Receivable, 2 Yr. CAGR %	-4.1	6	9.31	5.82	-0.24
Inventory, 2 Yr. CAGR %	1.83	5.62	4.51	-3.26	-3.63
Net Property, Plant and Equip., 2 Yr. CAGR %	0.7	2.16	-4.05	-5.15	-6.7
Total Assets, 2 Yr. CAGR %	1.47	4.07	3.69	-0.34	-1.11
Tangible Book Value, 2 Yr. CAGR %	9.01	4.18	4.71	0.92	0.68
Common Equity, 2 Yr. CAGR %	1.62	2.32	3.14	0.55	0.3
Cash From Operations, 2 Yr. CAGR %	15.29	3.53	-3.48	4.35	2.42
Capital Expenditures, 2 Yr. CAGR %	1.93	3.99	-16.71	-17.62	-25.21
Levered Free Cash Flow, 2 Yr. CAGR %	53.43	0.59	-8.81	15.69	16.91
Unlevered Free Cash Flow, 2 Yr. CAGR %	48.3	0.63	-8.39	15.63	15.81
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.15	3.89	6.42	1.08	-2.19
Gross Profit, 3 Yr. CAGR %	7.01	3.73	7.72	0.82	-0.92
EBITDA, 3 Yr. CAGR %	14.53	-3.52	7.43	5.31	9.8
EBITA, 3 Yr. CAGR %	27.94	-7.52	10.43	6.42	10
EBIT, 3 Yr. CAGR %	41.25	-7.11	13.89	9.46	11.2
Earnings From Cont. Operations, 3 Yr. CAGR %	31.93	25.51	-8.09	-16.08	-1
Net Income, 3 Yr. CAGR %	37.88	31.49	-5.68	-13.55	0.25
Normalized Net Income, 3 Yr. CAGR %	-20.42	-0.75	6.96	7.93	10.24
Diluted EPS Before Extra, 3 Yr. CAGR %	30.06	29.7	-5.2	-12.64	1.37
Accounts Receivable, 3 Yr. CAGR %	0.03	1.21	6	8.07	1.8
Inventory, 3 Yr. CAGR %	6.43	4.26	3.68	0.76	-2.46
Net Property, Plant and Equip., 3 Yr. CAGR %	1.96	0.44	-1.3	-3.49	-7.09
Total Assets, 3 Yr. CAGR %	4.24	2.63	3.51	1.41	0.05
Tangible Book Value, 3 Yr. CAGR %	19.78	7.44	4.47	2.05	2.12
Common Equity, 3 Yr. CAGR %	7.7	1.97	2.75	1.25	1.39
Cash From Operations, 3 Yr. CAGR %	35.13	2.74	6.96	-3.86	6.19
Capital Expenditures, 3 Yr. CAGR %	-0.1	-6.91	-1.14	-19.23	-20.65
Levered Free Cash Flow, 3 Yr. CAGR %	29.36	18.87	5.65	-1.52	16.79
Unlevered Free Cash Flow, 3 Yr. CAGR %	33.09	16.51	5.73	-1.3	16.11
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	12.88	3.32	3.78	2.71	1.98
Gross Profit, 5 Yr. CAGR %	14.35	3.51	4.6	3.06	3.21
EBITDA, 5 Yr. CAGR %	6.03	5.06	10.79	-0.67	11.28
EBITA, 5 Yr. CAGR %	3.32	6.29	18.12	-2.28	14.03
EBIT, 5 Yr. CAGR %	2.8	9.22	25.62	-1.76	16.02
Earnings From Cont. Operations, 5 Yr. CAGR %	24.73	33.8	8.4	10.62	-3.99
Net Income, 5 Yr. CAGR %	32.62	61.24	12.43	15.09	-2.14
Normalized Net Income, 5 Yr. CAGR %	10.84	20.99	-10.12	1.5	8.89
Diluted EPS Before Extra, 5 Yr. CAGR %	26.97	51.57	8.92	14.87	-1.53
Accounts Receivable, 5 Yr. CAGR %	14.7	7.45	3.64	3.03	3.46
Inventory, 5 Yr. CAGR %	28.96	6.44	5.66	1.19	0.69
Net Property, Plant and Equip., 5 Yr. CAGR %	-0.15	-0.61	-0.48	-1.83	-3.49
Total Assets, 5 Yr. CAGR %	10.88	3.66	4.02	1.43	1.64
Tangible Book Value, 5 Yr. CAGR %	24.59	15.52	13.51	4.78	2.94
Common Equity, 5 Yr. CAGR %	16.88	5.22	5.85	1.4	1.76
Cash From Operations, 5 Yr. CAGR %	17.44	20.19	18.11	3.38	5.12
Capital Expenditures, 5 Yr. CAGR %	-13.89	2.26	-7.11	-11.35	-11.58
Levered Free Cash Flow, 5 Yr. CAGR %	12.23	2.33	12.48	17.59	10.02
Unlevered Free Cash Flow, 5 Yr. CAGR %	13.56	3.76	14.62	16.15	9.65